Minims Cyclopentolate Hydrochloride Bausch & Lomb Uk (Cyclopentolate Hydrochloride Bp)

Cyclopentolate Hydrochloride, the active ingredient in Minims Cyclopentolate Hydrochloride Bausch & Lomb Uk, is an anticholinergic (muscarinic antagonist) presented as an eye‑drop for ocular use. It produces rapid mydriasis and cycloplegia to aid diagnostic and therapeutic procedures in ophthalmology.

GNH USA supplies Minims Cyclopentolate Hydrochloride Bausch & Lomb Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourcing the product from EU manufacturers that meet stringent quality standards. The distribution network ensures timely delivery and regulatory compliance across multiple regions.

Cyclopentolate Hydrochloride is used in ophthalmology to achieve pharmacologic dilation and paralysis of the ciliary muscle.

- Diagnostic eye examinations: provides rapid mydriasis to allow thorough retinal and optic nerve evaluation. - Uveitis management: produces cycloplegia to relieve pain from ciliary spasm and prevent posterior synechiae. - Pre‑operative ocular procedures: facilitates pupil dilation for laser or surgical interventions.

Cyclopentolate eye drops may cause ocular and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Blurred vision: temporary loss of near focus due to cycloplegia. - Light sensitivity: increased photophobia from pupil dilation. - Eye irritation: burning or stinging sensation on instillation. - Redness of the conjunctiva: mild hyperemia.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma: rapid increase in intra‑ocular pressure in predisposed eyes. - Systemic anticholinergic toxicity: confusion, dry mouth, tachycardia in susceptible patients. - Allergic reaction: swelling, itching, or rash around the eye.

When using Cyclopentolate Hydrochloride, consider the following precautions.

- Contraindication in narrow-angle glaucoma: avoid use as it may precipitate angle closure. - Use with caution in children: increased risk of systemic absorption. - Assess for hypersensitivity: discontinue if allergic signs appear. - Avoid contact lens wear: may cause lens discoloration or irritation. - Limit use before driving or operating machinery: blurred vision can impair performance. - Store at room temperature: keep in original container, protect from light and moisture.

Cyclopentolate Hydrochloride can interact with other medications; awareness of these interactions helps minimize risk.

Major Interactions (Avoid): - Other topical mydriatics (e.g., phenylephrine): additive dilation may increase intra‑ocular pressure. - Systemic anticholinergics (e.g., atropine): may enhance anticholinergic load, leading to systemic toxicity. - Beta‑blocker eye drops in narrow‑angle glaucoma: may mask pressure rise.

Moderate Interactions (Monitor Closely): - CYP450 inhibitors (e.g., erythromycin): may affect metabolism of absorbed drug. - Sedatives or CNS depressants: increased risk of confusion if systemic absorption occurs. - Oral antihistamines: additive anticholinergic effects may exacerbate dryness or tachycardia.